Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.22 billion.
Market Cap
1.12T
Revenue
105.22B
Profits
-42.66B
PE Ratio
n/a
Profit Margin
-40.55%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.02B | -1.27% | 1,144,609 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.16B | -0.12% | 657,779 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 61.48B | -1.84% | 580,485 | 3.21B |
| 4 | ARGX | argenx SE | 56.54B | -0.60% | 127,415 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.73B | -0.84% | 1,423,250 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 36.66B | -1.95% | 179,177 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.08B | -0.77% | 1,447,837 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.61B | -1.10% | 2,787,220 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.82B | 1.10% | 997,705 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.73B | -1.00% | 1,332,026 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.18B | 1.05% | 1,748,411 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.73B | 2.29% | 4,647,683 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.52B | 2.48% | 2,369,992 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.40B | 0.80% | 1,053,560 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.42B | 1.93% | 161,689 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.22B | -0.24% | 1,643,270 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.71B | 3.79% | 470,029 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.95B | 0.87% | 1,507,406 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.78B | -0.07% | 2,292,463 | 20.87M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.34B | -0.91% | 1,220,342 | 3.09B |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.14B | -0.43% | 581,401 | 4.16B |
| 22 | MRNA | Moderna, Inc. | 9.96B | 1.21% | 7,396,051 | 2.23B |
| 23 | TECH | Bio-Techne Corporation | 9.87B | -0.71% | 1,099,298 | 1.22B |
| 24 | CORT | Corcept Therapeutics Incorporated | 8.96B | 1.77% | 711,794 | 741.17M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.78B | -0.62% | 2,494,889 | 829.45M |
| 26 | NUVL | Nuvalent, Inc. | 8.31B | 0.14% | 311,069 | - |
| 27 | ABVX | ABIVAX Société Anonyme | 8.22B | -1.17% | 2,369,704 | 7.07M |
| 28 | CYTK | Cytokinetics, Incorporated | 8.16B | 3.17% | 1,207,311 | 87.21M |
| 29 | CAI | Caris Life Sciences, Inc. | 7.92B | 3.05% | 1,977,271 | 649.06M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.48B | 0.41% | 232,630 | 561.26M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.42B | -2.42% | 3,492,848 | 1.24B |
| 32 | MRUS | Merus N.V. | 7.30B | 0.08% | 1,300,905 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.07B | 1.31% | 469,563 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.93B | -0.21% | 386,210 | 302.00K |
| 35 | KRYS | Krystal Biotech, Inc. | 6.43B | 1.97% | 320,610 | 373.16M |
| 36 | PTCT | PTC Therapeutics, Inc. | 6.25B | 2.73% | 1,111,006 | 1.78B |
| 37 | PCVX | Vaxcyte, Inc. | 6.06B | -2.99% | 1,364,812 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.99B | 0.51% | 1,805,655 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.61B | 5.11% | 2,563,484 | 38.34M |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.47B | 1.71% | 519,830 | 209.22M |
| 41 | BLTE | Belite Bio, Inc | 5.29B | -0.20% | 331,735 | - |
| 42 | LEGN | Legend Biotech Corporation | 5.15B | 0.43% | 1,241,467 | 909.05M |
| 43 | APGE | Apogee Therapeutics, Inc. | 5.09B | 1.14% | 822,073 | - |
| 44 | CELC | Celcuity Inc. | 4.91B | 6.01% | 628,636 | - |
| 45 | ADMA | ADMA Biologics, Inc. | 4.80B | 2.26% | 1,797,619 | 488.56M |
| 46 | KYMR | Kymera Therapeutics, Inc. | 4.79B | 0.86% | 609,258 | 43.74M |
| 47 | PRAX | Praxis Precision Medicines, Inc. | 4.75B | 3.05% | 820,223 | 7.46M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.63B | 4.23% | 1,091,310 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.60B | -0.47% | 835,198 | 531.90M |
| 50 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.50B | 1.04% | 561,505 | 1.54M |
| 51 | AKRO | Akero Therapeutics, Inc. | 4.49B | -0.19% | 2,027,212 | - |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | 2.72% | 1,313,936 | 1.05B |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.39B | 9.74% | 4,544,024 | - |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.31B | 1.39% | 494,545 | 15.00M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.08B | 1.27% | 1,480,827 | 35.24M |
| 56 | IMVT | Immunovant, Inc. | 4.02B | 1.01% | 793,200 | - |
| 57 | ACLX | Arcellx, Inc. | 3.94B | -6.59% | 1,885,853 | 35.90M |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.81B | 3.94% | 1,541,153 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.69B | 1.01% | 150,679 | 471.79M |
| 60 | CGON | CG Oncology, Inc. | 3.63B | 5.49% | 670,048 | 2.17M |
| 61 | IRON | Disc Medicine, Inc. | 3.54B | 1.43% | 231,590 | - |
| 62 | RARE | Ultragenyx Pharmaceutical Inc. | 3.52B | 0.41% | 882,319 | 630.60M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.48B | 0.03% | 241,303 | 366.10M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.45B | 0.90% | 459,670 | 7.50M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.26B | 0.83% | 123,221 | 664.23M |
| 66 | TVTX | Travere Therapeutics, Inc. | 3.17B | 1.55% | 1,166,052 | 435.83M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.15B | 4.69% | 1,247,611 | 214.83M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.13B | -1.44% | 1,863,964 | 240.00M |
| 69 | MLYS | Mineralys Therapeutics, Inc. | 3.12B | 0.64% | 711,425 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.10B | 3.79% | 1,026,159 | 70.79M |
| 71 | FOLD | Amicus Therapeutics, Inc. | 3.06B | 1.50% | 1,729,779 | 598.70M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.96B | 3.29% | 1,685,006 | - |
| 73 | LQDA | Liquidia Corporation | 2.96B | 0.68% | 631,006 | 69.22M |
| 74 | DNLI | Denali Therapeutics Inc. | 2.95B | 6.84% | 2,114,053 | - |
| 75 | AAPG | Ascentage Pharma Group International | 2.88B | 1.15% | 1,339 | 54.52M |
| 76 | BEAM | Beam Therapeutics Inc. | 2.86B | 8.49% | 2,292,596 | 55.70M |
| 77 | NUVB | Nuvation Bio Inc. | 2.85B | -0.72% | 7,237,281 | 26.75M |
| 78 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.84B | 0.15% | 704,322 | 578.20M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.83B | 3.92% | 849,878 | 98.68M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.79B | 3.74% | 1,964,471 | 1.02B |
| 81 | VERA | Vera Therapeutics, Inc. | 2.72B | 3.27% | 1,573,992 | - |
| 82 | OCUL | Ocular Therapeutix, Inc. | 2.65B | 8.55% | 5,178,826 | 55.78M |
| 83 | ADPT | Adaptive Biotechnologies Corporation | 2.64B | 1.05% | 2,424,720 | 252.75M |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.60B | 4.19% | 767,231 | - |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.55B | 4.83% | 17,910,230 | 43.69M |
| 86 | EWTX | Edgewise Therapeutics, Inc. | 2.53B | 2.36% | 667,932 | - |
| 87 | TERN | Terns Pharmaceuticals, Inc. | 2.45B | -1.02% | 3,101,486 | - |
| 88 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | 4.44% | 2,886,224 | 2.41B |
| 89 | IBRX | ImmunityBio, Inc. | 2.27B | 4.84% | 11,128,299 | 82.56M |
| 90 | ZLAB | Zai Lab Limited | 2.22B | 1.16% | 733,913 | 441.63M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.20B | 3.38% | 543,620 | 825.94M |
| 92 | OLMA | Olema Pharmaceuticals, Inc. | 2.16B | 0.77% | 2,598,893 | - |
| 93 | MESO | Mesoblast Limited | 2.16B | 1.12% | 131,520 | 17.20M |
| 94 | GLPG | Galapagos NV | 2.09B | 0.14% | 42,287 | 336.64M |
| 95 | MAZE | Maze Therapeutics, Inc. | 2.05B | 2.82% | 438,395 | 2.50M |
| 96 | IMCR | Immunocore Holdings plc | 2.03B | 6.23% | 307,409 | 379.59M |
| 97 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 2.95% | 191,036 | 15.00M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 2.82% | 740,905 | 265.81M |
| 99 | GPCR | Structure Therapeutics Inc. | 1.99B | 3.89% | 863,879 | - |
| 100 | ZYME | Zymeworks Inc. | 1.98B | 0.80% | 441,801 | 134.48M |
| 101 | CLDX | Celldex Therapeutics, Inc. | 1.97B | 6.40% | 490,668 | 2.60M |
| 102 | DNTH | Dianthus Therapeutics, Inc. | 1.92B | 2.10% | 408,222 | 3.08M |
| 103 | VCEL | Vericel Corporation | 1.86B | -1.82% | 345,224 | 258.72M |
| 104 | IMNM | Immunome, Inc. | 1.85B | 3.87% | 1,264,990 | 9.68M |
| 105 | SION | Sionna Therapeutics, Inc. | 1.84B | 0.12% | 142,528 | - |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.82B | 6.95% | 1,336,450 | 83.69M |
| 107 | PHVS | Pharvaris N.V. | 1.81B | -5.28% | 561,264 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.77B | - | 499,272 | 205.63M |
| 109 | MNKD | MannKind Corporation | 1.76B | 2.42% | 1,906,739 | 313.79M |
| 110 | TRVI | Trevi Therapeutics, Inc. | 1.74B | -0.99% | 2,392,569 | - |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | 0.18% | 1,053,161 | 111.30M |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -0.22% | 1,014,392 | 44.79M |
| 113 | ATAI | Atai Beckley N.V. | 1.60B | 8.13% | 4,586,703 | 3.02M |
| 114 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.59B | 1.69% | 630,854 | -665.00K |
| 115 | INVA | Innoviva, Inc. | 1.55B | -0.48% | 422,695 | 388.52M |
| 116 | SVRA | Savara Inc. | 1.54B | 1.19% | 4,522,268 | - |
| 117 | UPB | Upstream Bio, Inc. | 1.52B | 4.00% | 489,870 | 2.80M |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.50B | 4.53% | 342,209 | - |
| 119 | IMTX | Immatics N.V. | 1.48B | 17.79% | 763,082 | 99.45M |
| 120 | QURE | uniQure N.V. | 1.44B | -9.38% | 8,769,046 | 15.75M |
| 121 | ARDX | Ardelyx, Inc. | 1.43B | 1.73% | 2,005,710 | 398.23M |
| 122 | MBX | MBX Biosciences, Inc. | 1.39B | -8.71% | 1,938,219 | - |
| 123 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.39B | 15.37% | 1,775,124 | 42.34M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | 12.69% | 5,029,874 | 6.31M |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.39B | 2.11% | 969,551 | 8.36M |
| 126 | SANA | Sana Biotechnology, Inc. | 1.38B | 15.66% | 10,561,604 | - |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.37B | 3.53% | 356,428 | - |
| 128 | FTRE | Fortrea Holdings Inc. | 1.34B | -0.72% | 1,703,968 | 2.76B |
| 129 | TNGX | Tango Therapeutics, Inc. | 1.33B | 3.24% | 2,406,748 | 66.50M |
| 130 | PGEN | Precigen, Inc. | 1.33B | 5.18% | 1,581,498 | 6.31M |
| 131 | KOD | Kodiak Sciences Inc. | 1.30B | 6.75% | 561,564 | - |
| 132 | XNCR | Xencor, Inc. | 1.29B | 4.27% | 656,174 | 150.13M |
| 133 | ELVN | Enliven Therapeutics, Inc. | 1.28B | 2.60% | 390,891 | - |
| 134 | BHVN | Biohaven Ltd. | 1.28B | 5.37% | 3,308,260 | - |
| 135 | WVE | Wave Life Sciences Ltd. | 1.26B | 5.88% | 1,874,341 | 109.23M |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.26B | 4.09% | 245,309 | 1.40M |
| 137 | MNMD | Mind Medicine (MindMed) Inc. | 1.23B | 4.48% | 978,194 | - |
| 138 | ANAB | AnaptysBio, Inc. | 1.19B | -1.58% | 420,536 | 169.47M |
| 139 | TYRA | Tyra Biosciences, Inc. | 1.17B | 1.23% | 1,038,058 | - |
| 140 | SEPN | Septerna, Inc. | 1.17B | -1.45% | 144,337 | 22.05M |
| 141 | NKTR | Nektar Therapeutics | 1.17B | 0.64% | 406,727 | 62.60M |
| 142 | CAPR | Capricor Therapeutics, Inc. | 1.17B | -14.87% | 8,409,946 | 11.13M |
| 143 | CVAC | CureVac N.V. | 1.15B | -0.78% | 490,364 | 83.00M |
| 144 | PHAR | Pharming Group N.V. | 1.13B | 9.90% | 46,212 | 362.27M |
| 145 | OCS | Oculis Holding AG | 1.13B | 3.08% | 74,124 | 992.00K |
| 146 | NTLA | Intellia Therapeutics, Inc. | 1.13B | 7.78% | 5,146,136 | 57.53M |
| 147 | URGN | UroGen Pharma Ltd. | 1.13B | -0.86% | 585,663 | 96.52M |
| 148 | GLUE | Monte Rosa Therapeutics, Inc. | 1.12B | 2.43% | 521,542 | 181.54M |
| 149 | XERS | Xeris Biopharma Holdings, Inc. | 1.11B | -0.22% | 1,010,477 | 266.14M |
| 150 | PVLA | Palvella Therapeutics, Inc. | 1.11B | 2.16% | 173,410 | - |
| 151 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | 3.92% | 1,052,287 | - |
| 152 | NVAX | Novavax, Inc. | 1.11B | -0.07% | 1,641,421 | 1.06B |
| 153 | ABCL | AbCellera Biologics Inc. | 1.09B | 4.73% | 3,099,325 | 35.33M |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.08B | 12.92% | 3,783,378 | - |
| 155 | NBTX | Nanobiotix S.A. | 1.05B | 4.76% | 26,383 | 11.93M |
| 156 | KURA | Kura Oncology, Inc. | 1.05B | 0.42% | 1,084,436 | 104.03M |
| 157 | BCAX | Bicara Therapeutics Inc. | 1.03B | 3.83% | 371,252 | - |
| 158 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | -0.20% | 390,291 | 147.19M |
| 159 | MDXG | MiMedx Group, Inc. | 1.01B | -2.08% | 503,188 | 393.44M |
| 160 | AVBP | ArriVent BioPharma, Inc. | 999.42M | 5.81% | 858,251 | - |
| 161 | CMPX | Compass Therapeutics, Inc. | 993.36M | 5.78% | 1,069,610 | 850.00K |
| 162 | JANX | Janux Therapeutics, Inc. | 985.22M | -4.27% | 2,051,542 | 10.00M |
| 163 | SPRY | ARS Pharmaceuticals, Inc. | 984.53M | 4.29% | 1,156,361 | 142.77M |
| 164 | VIR | Vir Biotechnology, Inc. | 955.09M | 9.49% | 2,887,182 | 16.86M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 953.79M | 6.27% | 1,467,395 | 192.44M |
| 166 | RAPT | RAPT Therapeutics, Inc. | 953.25M | 7.20% | 399,344 | - |
| 167 | TBPH | Theravance Biopharma, Inc. | 946.56M | -1.11% | 223,066 | 80.33M |
| 168 | GHRS | GH Research PLC | 940.37M | 5.42% | 191,303 | - |
| 169 | ERAS | Erasca, Inc. | 916.39M | -1.82% | 2,801,037 | - |
| 170 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 915.47M | 3.39% | 306,845 | - |
| 171 | YDES | YD Bio Limited | 907.80M | -0.39% | 43,910 | 510.36K |
| 172 | RZLT | Rezolute, Inc. | 889.68M | 1.32% | 1,989,810 | - |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 881.27M | 0.45% | 7,673,198 | 250.43M |
| 174 | LENZ | LENZ Therapeutics, Inc. | 870.49M | -0.64% | 385,043 | 17.50M |
| 175 | ALMS | Alumis Inc. | 867.51M | 5.99% | 1,024,666 | 22.12M |
| 176 | DAWN | Day One Biopharmaceuticals, Inc. | 863.50M | 1.20% | 1,699,672 | 133.67M |
| 177 | RIGL | Rigel Pharmaceuticals, Inc. | 855.11M | -0.21% | 312,223 | 282.08M |
| 178 | ABUS | Arbutus Biopharma Corporation | 852.96M | 0.11% | 515,953 | 14.61M |
| 179 | CRMD | CorMedix Inc. | 836.35M | 2.86% | 2,144,797 | 214.30M |
| 180 | KALV | KalVista Pharmaceuticals, Inc. | 828.45M | 11.80% | 2,395,035 | 1.43M |
| 181 | REPL | Replimune Group, Inc. | 823.26M | 1.70% | 1,037,111 | - |
| 182 | VSTM | Verastem, Inc. | 818.13M | 5.32% | 1,436,424 | 13.38M |
| 183 | ARVN | Arvinas, Inc. | 810.19M | -0.43% | 1,254,877 | 312.30M |
| 184 | GERN | Geron Corporation | 806.50M | -0.52% | 2,964,804 | 183.40M |
| 185 | MPLT | MapLight Therapeutics, Inc. | 795.58M | 7.74% | 474,171 | - |
| 186 | OMER | Omeros Corporation | 782.03M | 3.39% | 1,053,919 | - |
| 187 | GOSS | Gossamer Bio, Inc. | 781.16M | -1.32% | 1,710,933 | 44.05M |
| 188 | PROK | ProKidney Corp. | 776.15M | 4.88% | 1,180,476 | 744.00K |
| 189 | VALN | Valneva SE | 756.22M | 0.92% | 5,194 | 211.09M |
| 190 | ATXS | Astria Therapeutics, Inc. | 747.81M | 0.08% | 2,647,082 | 706.00K |
| 191 | GYRE | Gyre Therapeutics, Inc. | 715.31M | 3.01% | 37,145 | 107.27M |
| 192 | CTMX | CytomX Therapeutics, Inc. | 692.99M | 2.25% | 1,313,398 | 113.63M |
| 193 | MGTX | MeiraGTx Holdings plc | 690.61M | 5.67% | 354,405 | 27.42M |
| 194 | PRME | Prime Medicine, Inc. | 681.60M | 6.65% | 5,387,457 | 5.98M |
| 195 | ANNX | Annexon, Inc. | 672.99M | 5.49% | 2,219,400 | - |
| 196 | RGNX | REGENXBIO Inc. | 663.16M | 1.71% | 755,311 | 161.32M |
| 197 | LXEO | Lexeo Therapeutics, Inc. | 660.90M | 4.56% | 830,209 | - |
| 198 | CRVS | Corvus Pharmaceuticals, Inc. | 660.56M | 4.80% | 1,020,151 | - |
| 199 | EVMN | Evommune, Inc. | 659.60M | 3.35% | 92,832 | 3.00M |
| 200 | FDMT | 4D Molecular Therapeutics, Inc. | 640.48M | 4.77% | 586,067 | 120.00K |
| 201 | CGEM | Cullinan Therapeutics, Inc. | 625.62M | 0.86% | 636,092 | - |
| 202 | KROS | Keros Therapeutics, Inc. | 616.63M | 11.82% | 993,116 | 246.72M |
| 203 | PRTA | Prothena Corporation plc | 600.74M | 1.16% | 977,191 | 11.79M |
| 204 | JBIO | Jade Biosciences, Inc. | 575.74M | 4.29% | 297,041 | - |
| 205 | IVA | Inventiva S.A. | 572.02M | -0.24% | 230,993 | 19.93M |
| 206 | VTYX | Ventyx Biosciences, Inc. | 570.16M | 1.91% | 2,068,705 | - |
| 207 | DRUG | Bright Minds Biosciences Inc. | 566.46M | -1.80% | 120,040 | - |
| 208 | ASMB | Assembly Biosciences, Inc. | 563.72M | 1.83% | 36,174 | 37.19M |
| 209 | DSGN | Design Therapeutics, Inc. | 556.54M | - | 274,479 | - |
| 210 | ALT | Altimmune, Inc. | 554.06M | 3.91% | 2,772,092 | 20.00K |
| 211 | ABSI | Absci Corporation | 552.62M | 11.70% | 9,877,061 | 2.82M |
| 212 | ENGN | enGene Holdings Inc. | 547.02M | 2.25% | 164,729 | - |
| 213 | LYEL | Lyell Immunopharma, Inc. | 538.52M | 13.76% | 84,745 | 41.00K |
| 214 | NAGE | Niagen Bioscience, Inc. | 536.20M | 2.53% | 396,867 | 124.71M |
| 215 | MNPR | Monopar Therapeutics Inc. | 532.13M | 3.17% | 143,759 | - |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 523.46M | 2.22% | 948,811 | 180.61M |
| 217 | LXRX | Lexicon Pharmaceuticals, Inc. | 516.03M | 1.43% | 1,285,626 | 70.86M |
| 218 | IVVD | Invivyd, Inc. | 515.46M | -0.85% | 1,698,319 | 50.04M |
| 219 | BCYC | Bicycle Therapeutics plc | 498.76M | 0.70% | 278,897 | 28.34M |
| 220 | LBRX | LB Pharmaceuticals Inc | 489.79M | 3.20% | 162,422 | - |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 487.82M | -0.63% | 627,013 | 84.39M |
| 222 | FULC | Fulcrum Therapeutics, Inc. | 480.30M | -2.04% | 618,553 | 80.00M |
| 223 | DBVT | DBV Technologies S.A. | 476.67M | 0.77% | 774,978 | 5.50M |
| 224 | NBP | NovaBridge Biosciences | 465.67M | 4.94% | 487,463 | - |
| 225 | SLDB | Solid Biosciences Inc. | 461.62M | 14.16% | 1,251,567 | - |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 445.78M | 0.59% | 284,703 | - |
| 227 | BNTC | Benitec Biopharma Inc. | 442.41M | 3.86% | 447,822 | - |
| 228 | ADCT | ADC Therapeutics SA | 438.52M | -10.38% | 2,433,105 | 75.21M |
| 229 | IMRX | Immuneering Corporation | 435.52M | 0.07% | 467,812 | - |
| 230 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | 3.57% | 967,468 | 10.82M |
| 231 | AUTL | Autolus Therapeutics plc | 417.84M | 6.08% | 3,587,440 | 51.13M |
| 232 | ANRO | Alto Neuroscience, Inc. | 415.67M | -0.07% | 241,941 | - |
| 233 | AURA | Aura Biosciences, Inc. | 410.23M | 2.54% | 88,773 | - |
| 234 | ENTA | Enanta Pharmaceuticals, Inc. | 408.98M | -0.49% | 186,064 | 65.32M |
| 235 | GALT | Galectin Therapeutics Inc. | 408.76M | 11.23% | 676,509 | - |
| 236 | TECX | Tectonic Therapeutic, Inc. | 397.53M | 5.04% | 227,777 | - |
| 237 | AVXL | Anavex Life Sciences Corp. | 394.47M | -3.39% | 1,630,463 | - |
| 238 | PRTC | PureTech Health plc | 394.33M | - | 100 | 6.39M |
| 239 | OCGN | Ocugen, Inc. | 388.84M | 2.89% | 3,090,734 | 5.37M |
| 240 | NMRA | Neumora Therapeutics, Inc. | 383.47M | 1.10% | 861,860 | - |
| 241 | XOMA | XOMA Royalty Corporation | 383.01M | -0.23% | 26,984 | 47.11M |
| 242 | TENX | Tenax Therapeutics, Inc. | 378.93M | 1.63% | 177,474 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 369.58M | 2.25% | 894,266 | - |
| 244 | PEPG | PepGen Inc. | 366.43M | 1.52% | 435,892 | - |
| 245 | TRDA | Entrada Therapeutics, Inc. | 364.35M | 0.89% | 78,403 | 61.52M |
| 246 | CLLS | Cellectis S.A. | 357.62M | 3.65% | 72,130 | 82.55M |
| 247 | DRTS | Alpha Tau Medical Ltd. | 346.17M | 4.64% | 168,448 | - |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 345.11M | 9.75% | 641,153 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 337.27M | 5.10% | 8,230 | 17.00K |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 330.95M | 16.46% | 558,148 | 33.98M |
| 251 | ACRS | Aclaris Therapeutics, Inc. | 328.83M | 9.17% | 1,495,783 | 15.74M |
| 252 | SLN | Silence Therapeutics plc | 328.51M | 9.87% | 598,502 | 25.83M |
| 253 | AVTX | Avalo Therapeutics, Inc. | 326.50M | 6.10% | 366,631 | 192.00K |
| 254 | CTNM | Contineum Therapeutics, Inc. | 325.97M | 0.45% | 63,546 | - |
| 255 | NGNE | Neurogene Inc. | 325.91M | 4.57% | 412,849 | 925.00K |
| 256 | ALLO | Allogene Therapeutics, Inc. | 324.74M | -4.93% | 1,385,138 | 22.00K |
| 257 | MREO | Mereo BioPharma Group plc | 323.83M | 3.83% | 2,006,146 | 500.00K |
| 258 | FBRX | Forte Biosciences, Inc. | 322.39M | -1.26% | 40,010 | - |
| 259 | LRMR | Larimar Therapeutics, Inc. | 314.54M | 5.91% | 838,107 | - |
| 260 | VNDA | Vanda Pharmaceuticals Inc. | 308.78M | -0.85% | 837,984 | 212.07M |
| 261 | EPRX | Eupraxia Pharmaceuticals Inc. | 299.67M | -1.43% | 81,853 | - |
| 262 | CYBN | Cybin Inc. | 296.93M | 5.68% | 631,645 | - |
| 263 | ALDX | Aldeyra Therapeutics, Inc. | 292.69M | -0.10% | 753,615 | - |
| 264 | RLMD | Relmada Therapeutics, Inc. | 290.40M | -2.46% | 804,724 | - |
| 265 | CADL | Candel Therapeutics, Inc. | 290.14M | 5.28% | 1,276,245 | - |
| 266 | ACIU | AC Immune SA | 285.96M | 1.41% | 123,319 | 5.48M |
| 267 | OABI | OmniAb, Inc. | 280.71M | 3.72% | 370,292 | 21.09M |
| 268 | GUTS | Fractyl Health, Inc. | 272.03M | 3.39% | 3,535,426 | 3.00K |
| 269 | PYXS | Pyxis Oncology, Inc. | 271.78M | -5.11% | 702,003 | 2.82M |
| 270 | AARD | Aardvark Therapeutics, Inc. | 269.88M | 3.90% | 224,311 | - |
| 271 | MIST | Milestone Pharmaceuticals Inc. | 267.16M | 0.38% | 3,294,572 | - |
| 272 | PBYI | Puma Biotechnology, Inc. | 266.57M | 1.06% | 376,673 | 212.00M |
| 273 | PALI | Palisade Bio, Inc. | 265.97M | 5.62% | 6,387,385 | - |
| 274 | OBIO | Orchestra BioMed Holdings, Inc. | 265.95M | -3.09% | 141,410 | 2.82M |
| 275 | ABEO | Abeona Therapeutics Inc. | 264.92M | 3.35% | 769,751 | 400.00K |
| 276 | TARA | Protara Therapeutics, Inc. | 264.32M | 0.74% | 676,919 | - |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 262.71M | - | 303,872 | - |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 262.64M | 1.59% | 74,018 | 38.79M |
| 279 | FHTX | Foghorn Therapeutics Inc. | 259.00M | 3.15% | 143,304 | 24.52M |
| 280 | ACHV | Achieve Life Sciences, Inc. | 254.99M | -1.84% | 1,451,582 | - |
| 281 | SLS | SELLAS Life Sciences Group, Inc. | 253.11M | 15.38% | 9,968,150 | - |
| 282 | ETHZ | ETHZilla Corporation | 252.29M | 4.06% | 481,544 | 4.11M |
| 283 | CCCC | C4 Therapeutics, Inc. | 251.98M | -7.47% | 2,912,169 | 30.11M |
| 284 | ZURA | Zura Bio Limited | 251.64M | 5.16% | 233,443 | - |
| 285 | CBIO | Crescent Biopharma, Inc. | 251.12M | -4.21% | 2,456,535 | - |
| 286 | CABA | Cabaletta Bio, Inc. | 249.81M | 3.80% | 2,206,485 | - |
| 287 | IMMP | Immutep Limited | 248.47M | 4.12% | 103,657 | 3.31M |
| 288 | HUMA | Humacyte, Inc. | 243.45M | 0.78% | 2,841,720 | 1.57M |
| 289 | AVIR | Atea Pharmaceuticals, Inc. | 241.80M | 0.16% | 432,382 | - |
| 290 | VYGR | Voyager Therapeutics, Inc. | 241.30M | 2.60% | 401,131 | 31.32M |
| 291 | HRTX | Heron Therapeutics, Inc. | 238.37M | 2.36% | 2,383,602 | 155.10M |
| 292 | EDIT | Editas Medicine, Inc. | 238.19M | 3.17% | 1,315,439 | 46.38M |
| 293 | TNYA | Tenaya Therapeutics, Inc. | 234.77M | 6.02% | 1,907,238 | - |
| 294 | MDWD | MediWound Ltd. | 231.68M | 2.03% | 102,599 | 20.93M |
| 295 | TNXP | Tonix Pharmaceuticals Holding Corp. | 230.00M | 9.39% | 1,199,458 | 10.30M |
| 296 | PRQR | ProQR Therapeutics N.V. | 225.97M | 6.72% | 1,211,866 | 18.86M |
| 297 | ARMP | Armata Pharmaceuticals, Inc. | 215.80M | -0.83% | 69,749 | 5.05M |
| 298 | TLSA | Tiziana Life Sciences Ltd | 207.94M | 3.55% | 205,106 | - |
| 299 | SGMT | Sagimet Biosciences Inc. | 207.16M | -1.39% | 738,767 | - |
| 300 | QNCX | Quince Therapeutics, Inc. | 199.90M | 1.99% | 1,964,341 | - |
| 301 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 198.26M | 0.28% | 149,592 | - |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 194.06M | 2.88% | 493,754 | 97.60M |
| 303 | RANI | Rani Therapeutics Holdings, Inc. | 191.38M | -2.78% | 3,401,129 | 1.20M |
| 304 | STTK | Shattuck Labs, Inc. | 189.21M | 15.00% | 551,476 | 1.00M |
| 305 | SABS | SAB Biotherapeutics, Inc. | 180.91M | 2.70% | 195,680 | 114.70K |
| 306 | CRBU | Caribou Biosciences, Inc. | 180.86M | 4.03% | 908,011 | 9.30M |
| 307 | IPHA | Innate Pharma S.A. | 180.57M | - | 2,536 | 14.84M |
| 308 | SGMO | Sangamo Therapeutics, Inc. | 180.19M | 7.25% | 7,862,818 | 32.88M |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 179.42M | 4.21% | 334,908 | 1.09M |
| 310 | NTHI | NeOnc Technologies Holdings, Inc. | 179.36M | 2.79% | 48,902 | 59.99K |
| 311 | GNLX | Genelux Corporation | 177.56M | 1.51% | 92,351 | 8.00K |
| 312 | NVCT | Nuvectis Pharma, Inc. | 172.64M | 5.64% | 117,928 | - |
| 313 | ACTU | Actuate Therapeutics, Inc. | 169.91M | -1.62% | 63,168 | - |
| 314 | VOR | Vor Biopharma Inc. | 169.51M | -2.41% | 387,531 | - |
| 315 | VTGN | Vistagen Therapeutics, Inc. | 169.44M | 15.01% | 1,085,268 | 721.00K |
| 316 | IMMX | Immix Biopharma, Inc. | 163.86M | 17.59% | 1,179,431 | - |
| 317 | SAVA | Cassava Sciences, Inc. | 160.38M | 7.10% | 1,038,771 | - |
| 318 | CAMP | Camp4 Therapeutics Corporation | 159.86M | 4.92% | 48,515 | 3.80M |
| 319 | CDXS | Codexis, Inc. | 159.42M | 4.44% | 581,199 | 52.93M |
| 320 | MCRB | Seres Therapeutics, Inc. | 158.13M | 0.23% | 79,869 | 351.00K |
| 321 | SRZN | Surrozen, Inc. | 157.63M | 16.76% | 196,887 | 3.60M |
| 322 | ANIX | Anixa Biosciences, Inc. | 156.03M | -2.27% | 187,876 | - |
| 323 | MOLN | Molecular Partners AG | 155.36M | 1.46% | 1,113 | 856.30K |
| 324 | CGTX | Cognition Therapeutics, Inc. | 154.90M | -2.51% | 886,646 | - |
| 325 | IRD | Opus Genetics, Inc. | 154.48M | 7.18% | 365,885 | 14.63M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 154.33M | 0.70% | 2,245,982 | 70.00M |
| 327 | CGEN | Compugen Ltd. | 148.72M | 1.27% | 186,686 | 6.90M |
| 328 | CHRS | Coherus Oncology, Inc. | 148.67M | 0.82% | 716,548 | 277.73M |
| 329 | ELTX | Elicio Therapeutics, Inc. | 145.65M | 3.54% | 79,008 | - |
| 330 | CRDF | Cardiff Oncology, Inc. | 145.50M | 1.41% | 359,845 | 501.00K |
| 331 | CNTB | Connect Biopharma Holdings Limited | 142.55M | -3.77% | 53,937 | 762.00K |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 140.74M | 1.74% | 580,032 | 61.84M |
| 333 | UNCY | Unicycive Therapeutics, Inc. | 140.55M | 6.00% | 279,929 | - |
| 334 | INO | Inovio Pharmaceuticals, Inc. | 139.81M | 0.74% | 622,588 | 182.34K |
| 335 | AGEN | Agenus Inc. | 138.75M | -2.16% | 474,737 | 106.83M |
| 336 | NBY | NovaBay Pharmaceuticals, Inc. | 137.35M | 2.83% | 47,063 | 10.30M |
| 337 | MRSN | Mersana Therapeutics, Inc. | 137.07M | -1.54% | 57,606 | 33.18M |
| 338 | ACOG | Alpha Cognition Inc. | 136.39M | 7.97% | 119,563 | 7.43M |
| 339 | ALEC | Alector, Inc. | 132.07M | 6.14% | 2,485,605 | 69.05M |
| 340 | NKTX | Nkarta, Inc. | 131.40M | 3.93% | 637,529 | - |
| 341 | EXOZ | eXoZymes, Inc. | 130.00M | 3.33% | 483 | -700.00 |
| 342 | SPRO | Spero Therapeutics, Inc. | 128.74M | 0.22% | 226,401 | 40.55M |
| 343 | FATE | Fate Therapeutics, Inc. | 127.46M | 2.31% | 1,293,781 | 7.14M |
| 344 | PRLD | Prelude Therapeutics Incorporated | 126.89M | 11.59% | 259,291 | 10.50M |
| 345 | GANX | Gain Therapeutics, Inc. | 125.94M | 4.67% | 790,142 | - |
| 346 | COYA | Coya Therapeutics, Inc. | 125.23M | -2.68% | 90,851 | 3.99M |
| 347 | TTRX | Turn Therapeutics Inc. | 124.02M | 3.74% | 72,727 | - |
| 348 | ANVS | Annovis Bio, Inc. | 123.24M | - | 496,892 | - |
| 349 | GLSI | Greenwich LifeSciences, Inc. | 121.92M | 4.64% | 40,837 | - |
| 350 | DTIL | Precision BioSciences, Inc. | 121.20M | -0.49% | 180,289 | 698.00K |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 121.15M | 3.63% | 161,822 | - |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 119.94M | 13.62% | 382,865 | 14.38M |
| 353 | ELDN | Eledon Pharmaceuticals, Inc. | 119.86M | 0.31% | 1,025,679 | - |
| 354 | CLYM | Climb Bio, Inc. | 117.28M | -1.15% | 182,814 | - |
| 355 | OVID | Ovid Therapeutics Inc. | 116.43M | 3.48% | 1,428,596 | 6.61M |
| 356 | IKT | Inhibikase Therapeutics, Inc. | 113.89M | 5.21% | 551,313 | 1.00 |
| 357 | SLGL | Sol-Gel Technologies Ltd. | 110.90M | 0.08% | 18,851 | 18.97M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 110.53M | 6.68% | 202,528 | - |
| 359 | CNTX | Context Therapeutics Inc. | 109.25M | -5.96% | 1,545,085 | - |
| 360 | ORMP | Oramed Pharmaceuticals Inc. | 109.06M | 0.74% | 59,392 | 2.00M |
| 361 | SEER | Seer, Inc. | 107.11M | 1.59% | 227,025 | 16.38M |
| 362 | ONCY | Oncolytics Biotech Inc. | 104.10M | 8.19% | 1,435,968 | - |
| 363 | VANI | Vivani Medical, Inc. | 102.50M | 0.36% | 100,774 | - |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 102.31M | 13.07% | 122,403 | 151.93M |
| 365 | HURA | TuHURA Biosciences, Inc. | 102.26M | 4.45% | 73,656 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 101.87M | 2.17% | 597,228 | 26.87M |
| 367 | KPTI | Karyopharm Therapeutics Inc. | 100.43M | 7.88% | 125,289 | 142.53M |
| 368 | ATOS | Atossa Therapeutics, Inc. | 97.98M | 2.71% | 684,564 | - |
| 369 | SPRB | Spruce Biosciences, Inc. | 96.99M | 0.50% | 45,772 | 697.00K |
| 370 | ENTX | Entera Bio Ltd. | 96.76M | 2.43% | 88,625 | 124.00K |
| 371 | RPTX | Repare Therapeutics Inc. | 95.86M | 2.76% | 370,441 | 11.87M |
| 372 | HYFT | MindWalk Holdings Corp. | 95.31M | 10.43% | 314,194 | 18.21M |
| 373 | ANEB | Anebulo Pharmaceuticals, Inc. | 93.26M | -2.58% | 920 | - |
| 374 | ADAG | Adagene Inc. | 92.75M | -4.47% | 39,273 | 103.20K |
| 375 | ARTV | Artiva Biotherapeutics, Inc. | 92.66M | 2.79% | 38,868 | 251.00K |
| 376 | OTLK | Outlook Therapeutics, Inc. | 92.38M | 5.57% | 2,229,226 | 1.51M |
| 377 | ADVM | Adverum Biotechnologies, Inc. | 92.17M | 0.12% | 1,324,417 | 1.00M |
| 378 | ACET | Adicet Bio, Inc. | 91.31M | 5.16% | 1,731,904 | - |
| 379 | PSTV | Plus Therapeutics, Inc. | 90.02M | 9.75% | 8,926,534 | 5.26M |
| 380 | COEP | Coeptis Therapeutics Holdings, Inc. | 88.65M | 4.27% | 70,880 | 501.00K |
| 381 | MGNX | MacroGenics, Inc. | 87.30M | -1.43% | 2,271,607 | 127.63M |
| 382 | CBUS | Cibus, Inc. | 87.12M | 10.69% | 361,921 | 3.79M |
| 383 | VXRT | Vaxart, Inc. | 86.96M | 0.28% | - | 148.20M |
| 384 | THAR | Tharimmune, Inc. | 86.56M | -0.80% | 175,903 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 86.29M | 3.35% | 556,474 | 62.30M |
| 386 | TVGN | Tevogen Bio Holdings Inc. | 83.86M | -1.30% | 220,326 | - |
| 387 | CRVO | CervoMed Inc. | 83.27M | 8.70% | 48,616 | 6.16M |
| 388 | BMEA | Biomea Fusion, Inc. | 83.03M | 11.84% | 1,576,280 | - |
| 389 | IMUX | Immunic, Inc. | 82.99M | 6.15% | 1,001,207 | - |
| 390 | CSBR | Champions Oncology, Inc. | 82.73M | 0.17% | 5,084 | 56.88M |
| 391 | ATYR | aTyr Pharma, Inc. | 81.61M | 8.06% | 3,111,823 | 190.00K |
| 392 | PTHS | Pelthos Therapeutics Inc. | 80.71M | 0.61% | 23,494 | 7.41M |
| 393 | VRCA | Verrica Pharmaceuticals Inc. | 80.10M | 12.83% | 182,482 | 30.83M |
| 394 | PLRX | Pliant Therapeutics, Inc. | 79.88M | -15.58% | 15,317,450 | - |
| 395 | STRO | Sutro Biopharma, Inc. | 79.86M | 1.26% | 206,476 | 105.65M |
| 396 | BYSI | BeyondSpring Inc. | 79.37M | 1.58% | 4,915 | 1.88M |
| 397 | TIL | Instil Bio, Inc. | 77.11M | -1.04% | 64,135 | - |
| 398 | XBIT | XBiotech Inc. | 76.98M | -2.51% | 41,692 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 76.84M | 6.80% | 570,576 | - |
| 400 | MNOV | MediciNova, Inc. | 75.53M | 1.99% | 86,337 | 257.92K |
| 401 | IFRX | InflaRx N.V. | 74.86M | 8.33% | 783,712 | 73.73K |
| 402 | ALXO | ALX Oncology Holdings Inc. | 74.82M | 4.55% | 143,001 | - |
| 403 | IMA | ImageneBio, Inc. | 73.92M | 4.68% | 49,649 | 800.00K |
| 404 | ESLA | Estrella Immunopharma, Inc. | 73.64M | 13.37% | 178,464 | - |
| 405 | OKYO | OKYO Pharma Limited | 72.59M | 12.54% | 152,890 | - |
| 406 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 69.99M | 2.30% | 3,201,512 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 68.64M | - | 194,697 | - |
| 408 | NRXP | NRx Pharmaceuticals, Inc. | 68.28M | 0.83% | 341,762 | 242.00K |
| 409 | MGX | Metagenomi, Inc. | 67.40M | 1.41% | 316,383 | 30.91M |
| 410 | CALC | CalciMedica, Inc. | 67.00M | -0.85% | 36,126 | - |
| 411 | KRRO | Korro Bio, Inc. | 65.64M | 15.40% | 864,842 | 7.37M |
| 412 | PYPD | PolyPid Ltd. | 65.46M | -0.63% | 115,803 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 64.59M | -1.71% | 5,261 | 3.57M |
| 414 | OSTX | OS Therapies Incorporated | 64.09M | 4.00% | 191,374 | - |
| 415 | LITS | Lite Strategy, Inc. | 63.82M | -1.42% | 322,728 | - |
| 416 | ALGS | Aligos Therapeutics, Inc. | 62.58M | 3.04% | 66,328 | 2.65M |
| 417 | TCRX | TScan Therapeutics, Inc. | 61.86M | 6.86% | 1,075,630 | 8.42M |
| 418 | NTRB | Nutriband Inc. | 60.56M | 10.53% | 21,377 | 2.58M |
| 419 | ABVC | ABVC BioPharma, Inc. | 59.63M | -1.56% | 44,353 | 797.92K |
| 420 | SNTI | Senti Biosciences, Inc. | 58.37M | 0.91% | 97,414 | - |
| 421 | INKT | MiNK Therapeutics, Inc. | 57.28M | 11.65% | 35,851 | - |
| 422 | CELU | Celularity Inc. | 55.81M | -2.48% | 45,451 | 40.58M |
| 423 | EQ | Equillium, Inc. | 53.87M | 1.50% | 195,917 | 4.39M |
| 424 | JSPR | Jasper Therapeutics, Inc. | 52.19M | 13.03% | 1,910,171 | - |
| 425 | CVM | CEL-SCI Corporation | 50.42M | 5.54% | 54,232 | - |
| 426 | BCAB | BioAtla, Inc. | 50.17M | 3.28% | 815,382 | 11.00M |
| 427 | INMB | INmune Bio, Inc. | 50.11M | 7.10% | 677,021 | 50.00K |
| 428 | PDSB | PDS Biotechnology Corporation | 49.48M | 6.24% | 579,041 | - |
| 429 | IBO | Impact BioMedical Inc. | 49.17M | 7.50% | 63,005 | 25.00K |
| 430 | IOBT | IO Biotech, Inc. | 49.16M | 6.56% | 987,787 | - |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 48.78M | 9.49% | 574,161 | 1.14M |
| 432 | ICCC | ImmuCell Corporation | 48.21M | 1.52% | 47,036 | 27.77M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 46.93M | 3.41% | 214,208 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 46.20M | 3.65% | 73,174 | - |
| 435 | ANL | Adlai Nortye Ltd. | 46.13M | -8.09% | 20,370 | 1.94M |
| 436 | BTAI | BioXcel Therapeutics, Inc. | 46.04M | 10.21% | 448,330 | 752.00K |
| 437 | IPSC | Century Therapeutics, Inc. | 45.71M | 2.23% | 907,398 | 113.34M |
| 438 | KZR | Kezar Life Sciences, Inc. | 45.62M | -0.16% | 22,529 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 45.23M | - | 82,217 | 90.00K |
| 440 | QTTB | Q32 Bio Inc. | 44.54M | -0.28% | 874,902 | - |
| 441 | MAIA | MAIA Biotechnology, Inc. | 44.44M | 7.14% | 638,010 | - |
| 442 | EVAX | Evaxion A/S | 44.42M | 4.90% | 50,968 | 7.65M |
| 443 | GNTA | Genenta Science S.p.A. | 43.94M | -0.79% | 35,413 | - |
| 444 | NXTC | NextCure, Inc. | 43.81M | 7.44% | 31,006 | - |
| 445 | CUE | Cue Biopharma, Inc. | 43.72M | -1.05% | 183,687 | 7.10M |
| 446 | JUNS | Jupiter Neurosciences, Inc. | 42.00M | 0.83% | 29,803 | - |
| 447 | LTRN | Lantern Pharma Inc. | 41.49M | 4.80% | 43,861 | - |
| 448 | XCUR | Exicure, Inc. | 41.49M | 17.09% | 66,346 | 500.00K |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 39.64M | 2.55% | 92,973 | - |
| 450 | VERU | Veru Inc. | 39.16M | 0.83% | 72,427 | 16.89M |
| 451 | XLO | Xilio Therapeutics, Inc. | 38.98M | 5.17% | 725,546 | 31.80M |
| 452 | RADX | Radiopharm Theranostics Limited | 38.53M | 0.11% | 4,286 | 8.20M |
| 453 | SKYE | Skye Bioscience, Inc. | 38.47M | -1.64% | 159,630 | - |
| 454 | QNTM | Quantum BioPharma Ltd. | 37.09M | - | 59,702 | - |
| 455 | SER | Serina Therapeutics, Inc. | 37.00M | -0.29% | 9,359 | 116.00K |
| 456 | RNTX | Rein Therapeutics Inc. | 36.28M | - | 184,735 | - |
| 457 | KLTO | Klotho Neurosciences, Inc. | 36.27M | 5.09% | 765,172 | - |
| 458 | OKUR | OnKure Therapeutics, Inc. | 35.77M | 0.76% | 47,240 | - |
| 459 | GBIO | Generation Bio Co. | 35.71M | 1.34% | 26,392 | 15.27M |
| 460 | DYAI | Dyadic International, Inc. | 35.28M | 3.47% | 234,883 | 3.34M |
| 461 | MURA | Mural Oncology plc | 35.21M | -0.49% | 117,041 | - |
| 462 | RNXT | RenovoRx, Inc. | 34.82M | 5.04% | 139,824 | 928.00K |
| 463 | APLT | Applied Therapeutics, Inc. | 33.42M | 9.66% | 8,295,788 | 1.00M |
| 464 | FGEN | FibroGen, Inc. | 32.97M | 0.37% | 20,647 | 8.30M |
| 465 | PLUR | Pluri Inc. | 30.72M | -2.92% | 11,348 | 1.33M |
| 466 | APLM | Apollomics, Inc. | 30.69M | 3.32% | 5,310 | 198.00K |
| 467 | LNAI | Lunai Bioworks Inc. | 30.46M | 4.00% | 380,798 | - |
| 468 | GLTO | Galecto, Inc. | 30.15M | 2.62% | 241,475 | - |
| 469 | NRSN | NeuroSense Therapeutics Ltd. | 29.74M | -3.45% | 236,852 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 29.43M | -2.59% | 46,171 | 14.97M |
| 471 | ANTX | AN2 Therapeutics, Inc. | 29.32M | - | 70,055 | - |
| 472 | NRXS | NeurAxis, Inc. | 28.87M | -2.52% | 38,084 | 3.36M |
| 473 | PASG | Passage Bio, Inc. | 28.70M | 5.12% | 79,456 | - |
| 474 | IBIO | iBio, Inc. | 28.67M | 22.60% | 2,276,468 | 500.00K |
| 475 | PLRZ | Polyrizon Ltd. | 28.55M | 104.02% | 26,219,962 | - |
| 476 | HYPD | Hyperion DeFi, Inc. | 28.44M | 9.97% | 392,393 | 345.32K |
| 477 | IGC | IGC Pharma, Inc. | 28.43M | 1.36% | 445,700 | 1.11M |
| 478 | RLYB | Rallybio Corporation | 28.20M | 1.15% | 38,345 | 674.00K |
| 479 | ENLV | Enlivex Therapeutics Ltd. | 27.94M | 5.51% | 897,546 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 27.80M | 12.96% | 13,588,186 | - |
| 481 | CING | Cingulate Inc. | 26.62M | - | 131,076 | - |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 26.32M | -0.36% | 11,690 | 2.48M |
| 483 | LIMN | Liminatus Pharma, Inc. | 26.26M | -1.01% | 115,797 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 26.21M | - | 1,368,356 | - |
| 485 | NERV | Minerva Neurosciences, Inc. | 25.88M | 11.11% | 30,178 | - |
| 486 | DARE | Daré Bioscience, Inc. | 25.43M | 2.01% | 119,346 | -57.13K |
| 487 | LEXX | Lexaria Bioscience Corp. | 25.12M | 1.80% | 206,878 | 705.92K |
| 488 | BOLD | Boundless Bio, Inc. | 24.17M | - | 200,559 | - |
| 489 | KZIA | Kazia Therapeutics Limited | 23.90M | -1.66% | 332,352 | 1.20M |
| 490 | BCTX | BriaCell Therapeutics Corp. | 23.82M | -2.49% | 53,184 | - |
| 491 | ITRM | Iterum Therapeutics plc | 23.76M | 7.90% | 685,487 | 390.00K |
| 492 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.73M | -0.95% | 60,475 | - |
| 493 | MRKR | Marker Therapeutics, Inc. | 23.63M | 11.57% | 479,781 | 4.69M |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 23.27M | 10.04% | 418,494 | - |
| 495 | APVO | Aptevo Therapeutics Inc. | 23.25M | - | 486,668 | - |
| 496 | NEUP | Neuphoria Therapeutics Inc. | 22.85M | 1.43% | 70,610 | 15.65M |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 22.83M | 24.15% | 170,889 | - |
| 498 | PTN | Palatin Technologies, Inc. | 22.39M | 28.60% | 91,709 | 8.85M |
| 499 | NNVC | NanoViricides, Inc. | 21.96M | 9.91% | 328,677 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 20.20M | - | 1,056 | 573.19K |
| 501 | CASI | CASI Pharmaceuticals, Inc. | 20.10M | 4.07% | 25,926 | 26.85M |
| 502 | TRAW | Traws Pharma, Inc. | 18.94M | 12.32% | 430,176 | 2.85M |
| 503 | KAPA | Kairos Pharma, Ltd. | 18.93M | 7.61% | 96,964 | - |
| 504 | NCNA | NuCana plc | 18.44M | 4.36% | 42,606 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 18.35M | -1.41% | 100,636 | - |
| 506 | ALLR | Allarity Therapeutics, Inc. | 18.18M | 5.50% | 169,051 | - |
| 507 | OSRH | OSR Holdings, Inc. | 17.92M | 10.74% | 773,200 | -90.52K |
| 508 | LSTA | Lisata Therapeutics, Inc. | 17.92M | 5.56% | 19,285 | 1.07M |
| 509 | CRIS | Curis, Inc. | 17.32M | 7.20% | 170,197 | 11.65M |
| 510 | LPCN | Lipocine Inc. | 17.27M | 0.65% | 16,112 | 4.32M |
| 511 | TPST | Tempest Therapeutics, Inc. | 16.85M | 4.59% | 241,671 | - |
| 512 | SNGX | Soligenix, Inc. | 16.64M | 6.41% | 216,504 | 2.34K |
| 513 | NCEL | NewcelX Ltd. | 16.41M | 1.69% | 29,849 | - |
| 514 | PMN | ProMIS Neurosciences, Inc. | 16.18M | 2.11% | 18,103 | - |
| 515 | MTVA | MetaVia Inc. | 16.16M | 11.35% | 442,571 | - |
| 516 | ABP | Abpro Holdings, Inc. | 16.11M | 4.22% | 19,828 | 183.00K |
| 517 | CLRB | Cellectar Biosciences, Inc. | 16.02M | 2.41% | 13,358 | - |
| 518 | FBLG | FibroBiologics, Inc. | 15.92M | 1.88% | 1,529,794 | - |
| 519 | CANF | Can-Fite BioPharma Ltd. | 15.84M | -0.88% | 1,131,872 | 560.00K |
| 520 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.76M | 5.36% | 44,881 | - |
| 521 | PULM | Pulmatrix, Inc. | 15.56M | -3.83% | 5,416 | 3.00K |
| 522 | MBRX | Moleculin Biotech, Inc. | 15.56M | 0.66% | 116,411 | - |
| 523 | BCDA | BioCardia, Inc. | 15.49M | 2.82% | 107,616 | 3.00K |
| 524 | PCSA | Processa Pharmaceuticals, Inc. | 15.32M | 1.27% | 1,485,932 | - |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 15.26M | -0.40% | 66,311 | - |
| 526 | ATHA | Athira Pharma, Inc. | 15.26M | 0.52% | 7,690 | - |
| 527 | PHIO | Phio Pharmaceuticals Corp. | 14.53M | 4.66% | 361,845 | - |
| 528 | BLRX | BioLineRx Ltd. | 14.53M | 3.73% | 13,094 | 12.74M |
| 529 | COCP | Cocrystal Pharma, Inc. | 14.34M | - | 48,250 | - |
| 530 | DWTX | Dogwood Therapeutics, Inc. | 14.03M | -1.45% | 75,874 | - |
| 531 | LGVN | Longeveron Inc. | 13.59M | 0.11% | 228,142 | 1.44M |
| 532 | SYBX | Synlogic, Inc. | 13.45M | -11.54% | 730,644 | 8.00K |
| 533 | ICU | SeaStar Medical Holding Corporation | 12.77M | 4.21% | 1,320,248 | 881.00K |
| 534 | SNSE | Sensei Biotherapeutics, Inc. | 12.61M | 14.94% | 324,703 | - |
| 535 | VYNE | VYNE Therapeutics Inc. | 12.53M | 0.45% | 388,197 | 524.00K |
| 536 | IMNN | Imunon, Inc. | 12.40M | 2.15% | 57,696 | - |
| 537 | AKTX | Akari Therapeutics, Plc | 12.35M | 1.62% | 504,432 | - |
| 538 | BIVI | BioVie Inc. | 12.14M | 1.26% | 111,105 | - |
| 539 | EDSA | Edesa Biotech, Inc. | 12.10M | -0.16% | 28,185 | - |
| 540 | IMRN | Immuron Limited | 11.92M | 0.65% | 591,313 | 4.78M |
| 541 | GOVX | GeoVax Labs, Inc. | 11.43M | -3.94% | 566,409 | 3.35M |
| 542 | APM | Aptorum Group Limited | 11.40M | 2.19% | 38,341 | - |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 11.27M | 2.67% | 53,667 | - |
| 544 | PPCB | Propanc Biopharma, Inc. | 10.64M | -4.25% | 1,117,271 | - |
| 545 | BRTX | BioRestorative Therapies, Inc. | 10.23M | 6.67% | 31,522 | 383.40K |
| 546 | ERNA | Ernexa Therapeutics Inc. | 9.89M | 9.57% | 98,926 | 1,000.00 |
| 547 | BOLT | Bolt Biotherapeutics, Inc. | 9.89M | -2.28% | 26,227 | 5.20M |
| 548 | ASBP | Aspire Biopharma Holdings, Inc. | 9.81M | 2.47% | 13,028,721 | 1.94K |
| 549 | MBIO | Mustang Bio, Inc. | 9.71M | 11.76% | 94,808 | - |
| 550 | SLXN | Silexion Therapeutics Corp | 9.71M | 12.88% | 111,460 | - |
| 551 | EVGN | Evogene Ltd. | 9.24M | 2.83% | 42,568 | 8.02M |
| 552 | AEON | AEON Biopharma, Inc. | 8.86M | -8.16% | 147,870 | - |
| 553 | BGMS | Bio Green Med Solution, Inc. | 8.65M | 4.44% | 55,457 | 81.00K |
| 554 | KALA | KALA BIO, Inc. | 8.62M | 13.51% | 177,791,706 | - |
| 555 | INAB | IN8bio, Inc. | 8.53M | 5.14% | 34,277 | - |
| 556 | PMCB | PharmaCyte Biotech, Inc. | 8.41M | 57.80% | 110,884,763 | - |
| 557 | CELZ | Creative Medical Technology Holdings, Inc. | 8.35M | 2.22% | 229,021 | 6.00K |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 8.16M | -2.38% | 25,700 | 451.00K |
| 559 | TOVX | Theriva Biologics, Inc. | 8.15M | 20.74% | 6,774,264 | - |
| 560 | TCRT | Alaunos Therapeutics, Inc. | 8.12M | 2.25% | 26,619 | 6.00K |
| 561 | ALZN | Alzamend Neuro, Inc. | 8.06M | 2.91% | 21,562 | - |
| 562 | KPRX | Kiora Pharmaceuticals, Inc. | 7.96M | 3.33% | 43,125 | 20.00K |
| 563 | LYRA | Lyra Therapeutics, Inc. | 7.95M | 6.92% | 33,557 | 600.00K |
| 564 | RNAZ | TransCode Therapeutics, Inc. | 7.88M | 2.14% | 2,751 | - |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 7.78M | 2.89% | 351,732 | - |
| 566 | ADXN | Addex Therapeutics Ltd | 7.64M | -6.78% | 8,331 | 198.82K |
| 567 | GNPX | Genprex, Inc. | 7.51M | 16.96% | 1,833,456 | - |
| 568 | PPBT | Purple Biotech Ltd | 7.45M | 7.99% | 302,052 | - |
| 569 | PHGE | BiomX Inc. | 7.28M | 5.76% | 26,925 | - |
| 570 | ACXP | Acurx Pharmaceuticals, Inc. | 7.17M | 4.88% | 40,149 | - |
| 571 | GRI | GRI Bio, Inc. | 6.92M | 6.88% | 169,726 | - |
| 572 | APRE | Aprea Therapeutics, Inc. | 6.69M | 2.91% | 83,831 | 488.24K |
| 573 | GTBP | GT Biopharma, Inc. | 6.68M | 3.22% | 1,509,388 | - |
| 574 | CYCN | Cyclerion Therapeutics, Inc. | 6.49M | 11.44% | 144,742 | 2.86M |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 6.25M | 6.54% | 335,822 | - |
| 576 | VIVS | VivoSim Labs, Inc. | 6.23M | 8.56% | 109,904 | 140.00K |
| 577 | SILO | Silo Pharma, Inc. | 6.01M | -0.94% | 62,942 | 72.10K |
| 578 | REVB | Revelation Biosciences, Inc. | 5.95M | 5.42% | 163,162 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 5.84M | 3.77% | 51,272 | 4.49M |
| 580 | XBIO | Xenetic Biosciences, Inc. | 5.68M | 2.48% | 11,610 | 2.86M |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.62M | 6.89% | 5,492 | 15.78K |
| 582 | HCWB | HCW Biologics Inc. | 5.48M | -1.46% | 23,633 | 422.03K |
| 583 | SLRX | Salarius Pharmaceuticals, Inc. | 5.25M | 4.14% | 563,728 | - |
| 584 | MTNB | Matinas BioPharma Holdings, Inc. | 4.81M | 0.09% | 37,204 | - |
| 585 | ONCO | Onconetix, Inc. | 4.62M | -1.00% | 37,261 | 1.22M |
| 586 | JAGX | Jaguar Health, Inc. | 4.38M | 4.90% | 165,622 | 11.79M |
| 587 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.23M | -1.96% | 71,707 | 1.36M |
| 588 | XRTX | XORTX Therapeutics Inc. | 4.21M | -0.46% | 25,399 | - |
| 589 | VRAX | Virax Biolabs Group Limited | 4.18M | -7.06% | 5,850,442 | 2.99K |
| 590 | ARTL | Artelo Biosciences, Inc. | 4.08M | 22.38% | 619,102 | - |
| 591 | CNSP | CNS Pharmaceuticals, Inc. | 4.03M | -2.40% | 6,733 | - |
| 592 | AZTR | Azitra, Inc. | 3.74M | -1.37% | 173,116 | 7.50K |
| 593 | INDP | Indaptus Therapeutics, Inc. | 3.72M | -1.62% | 13,716 | - |
| 594 | ELAB | PMGC Holdings Inc. | 3.65M | -4.10% | 20,838 | 285.95K |
| 595 | ENVB | Enveric Biosciences, Inc. | 3.65M | 1.19% | 51,948 | - |
| 596 | OGEN | Oragenics, Inc. | 3.55M | -1.49% | 52,605 | - |
| 597 | SCNI | Scinai Immunotherapeutics Ltd. | 3.44M | -6.08% | 48,002 | 1.15M |
| 598 | PBM | Psyence Biomedical Ltd. | 3.39M | 1.69% | 196,537 | - |
| 599 | PTIX | Protagenic Therapeutics, Inc. | 3.31M | -5.26% | 120,300 | - |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 3.10M | 2.04% | 16,813 | 104.90K |
| 601 | SPRC | SciSparc Ltd. | 2.97M | 7.02% | 241,043 | 1.31M |
| 602 | CDT | CDT Equity Inc. | 2.93M | 6.51% | 347,945 | - |
| 603 | CMND | Clearmind Medicine Inc. | 2.60M | 13.41% | 11,396,405 | - |
| 604 | DRMA | Dermata Therapeutics, Inc. | 2.59M | -16.28% | 293,360 | - |
| 605 | MLEC | Moolec Science SA | 1.87M | 3.74% | 81,324 | 7.83M |
| 606 | ADTX | Aditxt, Inc. | 1.62M | 5.53% | 317,066 | 5.95K |